Compare
CapsoVision, Inc vs Escalon Medical Corp vs QT Imaging Holdings, Inc. vs Nuwellis, Inc.
| Latest fiscal year | CapsoVision, Inc CV | Escalon Medical Corp ESMC | QT Imaging Holdings, Inc. QTI | Nuwellis, Inc. NUWE |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $13.55M | $12.74M | $18.93M | $8.27M |
| Revenue growth (YoY) | +15.3% | +5.7% | +287.9% | -5.4% |
| Gross margin | 52.9% | 43.7% (computed) | 45.4% | 62.0% |
| Operating margin | -188.3% | 0.4% | -23.4% | -134.3% |
| Net margin | -186.8% | 31.5% | -111.4% | -211.9% |
| Net income | -$25.32M | $4.01M | -$21.08M | -$17.52M |
| EPS (Diluted) | -$1.03 | $0.27 | -$2.01 | -$25.39 |
| Operating cash flow | -$22.86M | -$402.6K | -$8.96M | -$10.81M |
| Free cash flow | -$22.95M | -$407.0K | -$9.08M | -$10.90M |
| Cash & equivalents | n/a | $3.07M | $10.41M | $1.08M |
| Total assets | $18.16M | $9.13M | $23.02M | $6.12M |
| Total liabilities | $4.90M | $3.20M | $16.58M | $3.49M |
| Shareholders' equity | $13.26M | $5.93M | $6.45M | $2.62M |
| Return on year-end equity | -190.9% | 67.7% | -327.1% | -667.7% |
| Shares outstanding | 46.87M | 7.42M | 11.90M | 1.69M |
Revenue, most recent five fiscal years
| Fiscal year | CapsoVision, Inc | Escalon Medical Corp | QT Imaging Holdings, Inc. | Nuwellis, Inc. |
|---|---|---|---|---|
| Latest | $13.55M Ended 2025-12-31 | $12.74M Ended 2026-06-30 | $18.93M Ended 2025-12-31 | $8.27M Ended 2025-12-31 |
| 1 year earlier | $11.76M Ended 2024-12-31 | $12.05M Ended 2025-06-30 | $4.88M Ended 2024-12-31 | $8.74M Ended 2024-12-31 |
| 2 years earlier | n/a | $11.98M Ended 2024-06-30 | $40.4K Ended 2023-12-31 | $8.86M Ended 2023-12-31 |
| 3 years earlier | n/a | $12.18M Ended 2023-06-30 | n/a | $8.54M Ended 2022-12-31 |
| 4 years earlier | n/a | $10.70M Ended 2022-06-30 | n/a | $7.92M Ended 2021-12-31 |